Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

corticosteroids

corticosteroids is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 5
Pipeline programs 11
News articles 0
Drug details — corticosteroids
Class
—
Route
—
Patents
5
Programs
11
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

corticosteroids is an FDA-listed pharmaceutical active ingredient.

Key facts

INN corticosteroids

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 2G-MSC-GVHD Phase 2 · George Institute for · Patients who have developed acute GVHD refractory to cortico
  2. IL-6 aGVHD Siltuximab: A phase II study to as... Phase 2 · Disc Medicine · Grade III/IV acute graft versus host disease of the liver of
  3. IVERMECTIN Phase 2 · George Institute for · Strongyloidiasis is caused by a parasite that is globally di
  4. Steroids switch Phase 2 · United Therapeutics Europe · Prostate Cancer
  5. corticosteroids Phase 2 · Chinese Academy of · Acute Severe Colitis (ASC)
  6. corticosteroids combined with immunoglobulin and romiplostim Phase 2 · Chinese Academy of · Primary Immune Thrombocytopenia
  7. An open-label for inteneded for treatment of - ac… Phase 1 · Anaxis Pharma · inteneded for treatment of - active rheumatoid arthritis in
  8. CB-03-01/39 Phase 1 · Cassopeia Pharmaceuticals Pvt · Test of vasocontriction properties for classification of top

Related patents

Browse patents

  1. US 11197822

    Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

    Expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10456390

    Combinations comprising MABA compounds and corticosteroids

    Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10272037

    Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

    Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9782347

    Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8679545

    Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

    Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is corticosteroids?

corticosteroids is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.